Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kamil Ali-jackson currently holds 15,125 shares of Aclaris Therapeutics, Inc. (ACRS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kamil Ali-jackson has been a net seller of ACRS stock. They have purchased $100.0K and sold $3.3M worth of shares.
Kamil Ali-jackson's most recent insider trade was on May 15, 2026, when they sold 5,750 shares at $0.00 per share.
Kamil Ali-jackson serves as Executive at Aclaris Therapeutics, Inc. (ACRS). They have executed 80 insider transactions totaling $3.4M over their tenure at the company.
Kamil Ali-jackson holds the position of Executive at Aclaris Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Kamil Ali-jackson has shown a selling trading pattern, with $100.0K in total purchases and $3.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kamil Ali-jackson was on May 5, 2021, when they sold $347.6K worth of ACRS shares. This transaction involved 14,502 shares at $23.97 per share.
Kamil Ali-jackson currently owns 15,125 shares of Aclaris Therapeutics, Inc. (ACRS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kamil Ali-jackson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kamil Ali-jackson has 80 Form 4 filings on record as an insider at Aclaris Therapeutics, Inc..
Set alerts for Kamil Ali-jackson and 40,000+ other insiders.